Study of Melphalan Flufenamide (Melflufen) + Dex With Bortezomib or Daratumumab in Patients With RRMM
Clinical trial NCT03481556 · TERMINATED
Trial details
- NCT number
- NCT03481556
- Sponsor
- Oncopeptides AB
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-12
- Primary completion
- 2022-02-02
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.